Primary Aldosteronism Due to Aldosterone Producing Adenoma Clinical Trial
Official title:
Efficacy and Safety of Renal Sympathetic Denervation From The Adventitia on Hypertension in Patients With Primary Aldosteronism
Renal sympathetic denervation from the intima of renal arteries has become an important method for the treatment of resistant hypertension, but renal sympathetic nerve are mainly located in the adventitia, and there is no report about renal sympathetic denervation from the renal adventitia. Primary aldosteronism is an important factor of secondary hypertension, tumor aldosterone in unilateral adrenal can increase the concentration of plasma aldosterone, in some patients blood pressure control is still not desirable after resection of tumor aldosterone. This study intends to conduct renal sympathetic denervation ablation from the adventitia to observe its efficacy and safety on blood pressure of patients with primary aldosterone.
Renal sympathetic denervation from the intima of renal arteries has become an important method for the treatment of resistant hypertension, but renal sympathetic nerve are mainly located in the adventitia, and there is no report about renal sympathetic denervation from the renal adventitia. Primary aldosteronism is an important factor of secondary hypertension, tumor aldosterone in unilateral adrenal can increase the concentration of plasma aldosterone, in some patients blood pressure control is still not desirable after resection of tumor aldosterone. This study intends to conduct renal sympathetic denervation ablation（RDN）from the adventitia to observe its efficacy and safety on blood pressure of patients with primary aldosterone. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05361083 -
First-in-human Evaluation of [18F]CETO
|
Early Phase 1 | |
| Recruiting |
NCT04428827 -
Outcome of Patients With Primary Aldosteronism
|
||
| Completed |
NCT03990701 -
Primary Aldosteronism and Surgically Curable Forms in Hypertension Patients Using 11C-Metomidate
|
Early Phase 1 | |
| Completed |
NCT04761354 -
Predicting Reduction of Hypertension After Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis
|
||
| Completed |
NCT04185857 -
MRA and ARB Treatment in Screening of Primary Aldosteronism
|
||
| Completed |
NCT04378387 -
Ipsilateral and Contralateral Index for the Interpretation of Adrenal Vein Sampling (AVS) in Primary Aldosteronism
|
||
| Completed |
NCT03174847 -
Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism
|
||
| Recruiting |
NCT06100367 -
11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT05927961 -
Spatial Proteomics Profiles of Aldosterone-producing Adenoma and Unilateral Hyperplasia
|
||
| Not yet recruiting |
NCT03449797 -
Rapid Cortisol Assay in Adrenal Vein Sampling
|
N/A |